Published in Antimicrob Agents Chemother on July 28, 2014
Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol (2006) 6.34
Glutathione metabolism and its selective modification. J Biol Chem (1988) 4.89
Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene. J Bacteriol (1997) 3.60
Intracellular survival of Burkholderia pseudomallei. Infect Immun (1996) 3.56
Regulation of glutathione synthesis. Mol Aspects Med (2008) 3.40
Ascorbate and glutathione: the heart of the redox hub. Plant Physiol (2011) 3.39
Gamma interferon limits access of Listeria monocytogenes to the macrophage cytoplasm. J Exp Med (1989) 3.08
Melioidosis: a clinical overview. Br Med Bull (2011) 2.83
Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J Immunol (2005) 2.79
Burkholderia pseudomallei induces cell fusion and actin-associated membrane protrusion: a possible mechanism for cell-to-cell spreading. Infect Immun (2000) 2.70
Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Annu Rev Microbiol (2010) 2.69
Characterization of Burkholderia pseudomallei and Burkholderia pseudomallei-like strains. Epidemiol Infect (1997) 2.69
Factors affecting the escape of Francisella tularensis from the phagolysosome. J Med Microbiol (2004) 2.57
Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect Immun (1999) 2.41
Dissection of the Burkholderia intracellular life cycle using a photothermal nanoblade. Proc Natl Acad Sci U S A (2011) 1.91
Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med (2008) 1.89
The regulation of hepatic glutathione. Annu Rev Pharmacol Toxicol (1985) 1.84
Management of melioidosis. Expert Rev Anti Infect Ther (2006) 1.83
The statistics of synergism. J Mol Cell Cardiol (1998) 1.76
The chemistry and biological activities of N-acetylcysteine. Biochim Biophys Acta (2013) 1.72
Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection. J Infect Dis (2005) 1.56
Burkholderia pseudomallei interferes with inducible nitric oxide synthase (iNOS) production: a possible mechanism of evading macrophage killing. Microbiol Immunol (2001) 1.54
Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis. Future Microbiol (2012) 1.52
Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line. Cell Death Differ (2002) 1.48
Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice. Infect Immun (2006) 1.45
Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages. Infect Immun (2009) 1.45
Burkholderia pseudomallei type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages. Infect Immun (2008) 1.44
Role of reactive nitrogen and oxygen intermediates in gamma interferon-stimulated murine macrophage bactericidal activity against Burkholderia pseudomallei. Infect Immun (1997) 1.44
Glutathione metabolism. Methods Enzymol (1995) 1.44
Strategies for Intracellular Survival of Burkholderia pseudomallei. Front Microbiol (2011) 1.35
Actin-based motility of Burkholderia pseudomallei involves the Arp 2/3 complex, but not N-WASP and Ena/VASP proteins. Cell Microbiol (2003) 1.31
The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr (2005) 1.26
Localized reactive oxygen and nitrogen intermediates inhibit escape of Listeria monocytogenes from vacuoles in activated macrophages. J Immunol (2003) 1.24
Depletion of glutathione by inhibition of biosynthesis. Methods Enzymol (1981) 1.18
Glutathione. Arabidopsis Book (2011) 1.12
Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection. Antimicrob Agents Chemother (2010) 1.08
Glutathione biosynthesis and its inhibition. Methods Enzymol (1995) 1.07
Exploitation of host cells by Burkholderia pseudomallei. Int J Med Microbiol (2004) 1.05
Caspase-1 mediates resistance in murine melioidosis. Infect Immun (2009) 1.04
Induction of iNOS expression and antimicrobial activity by interferon (IFN)-beta is distinct from IFN-gamma in Burkholderia pseudomallei-infected mouse macrophages. Clin Exp Immunol (2004) 1.01
Differential intracellular fate of Burkholderia pseudomallei 844 and Burkholderia thailandensis UE5 in human monocyte-derived dendritic cells and macrophages. BMC Immunol (2009) 0.99
Burkholderia pseudomallei transcriptional adaptation in macrophages. BMC Genomics (2012) 0.95
Melioidosis and chronic granulomatous disease. Proc R Soc Med (1971) 0.92
Defense Mechanisms of Hepatocytes Against Burkholderia pseudomallei. Front Microbiol (2012) 0.92
Glutathione synthesis and its role in redox signaling. Semin Cell Dev Biol (2012) 0.90
Distinct roles for nitric oxide in resistant C57BL/6 and susceptible BALB/c mice to control Burkholderia pseudomallei infection. BMC Immunol (2011) 0.90
Glutathione distribution in normal and oxidatively stressed cells. Exp Cell Res (2003) 0.89
Buthionine sulfoximine inhibition of cystine uptake and glutathione biosynthesis in human lung carcinoma cells. Toxicol Appl Pharmacol (1985) 0.87
Burkholderia pseudomallei infection in chronic granulomatous disease. Eur J Pediatr (2005) 0.86
Involvement of the MyD88-independent pathway in controlling the intracellular fate of Burkholderia pseudomallei infection in the mouse macrophage cell line RAW 264.7. Microbiol Immunol (2010) 0.85
Interplay between drug efflux and antioxidants in Escherichia coli resistance to antibiotics. Antimicrob Agents Chemother (2010) 0.84
Measurement of the intracellular distribution of reduced glutathione in cultured rat hepatocytes using monochlorobimane and confocal laser scanning microscopy. Toxicol In Vitro (2002) 0.81
Melioidosis: refining management of a tropical time bomb. Lancet (2013) 0.78
Use of flow cytometry and monochlorobimane to quantitate intracellular glutathione concentrations in feline leukocytes. Vet Immunol Immunopathol (2006) 0.77